South Korean Pharmaceuticals & Biotech Leverage Leaders

Hanmi Pharm

Market Cap: ₩6.7t

A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.

Peptron

Market Cap: ₩4.3t

Engages in the development of peptide-based medicines.

SK Biopharmaceuticals

Market Cap: ₩7.2t

A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.

ALTEOGEN

Market Cap: ₩21.7t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Samsung BiologicsLtd

Market Cap: ₩73.9t

Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.

Voronoi

Market Cap: ₩3.0t

Researches, develops, and discovers small molecule kinase inhibitors in South Korea.

PharmaResearch

Market Cap: ₩4.6t

Operates as a biopharmaceutical company primarily in South Korea.

ABL Bio

Market Cap: ₩4.2t

A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.

Sam Chun Dang Pharm

Market Cap: ₩4.0t

Engages in the manufacturing and sale of pharmaceutical products in South Korea.

Celltrion

Market Cap: ₩46.4t

A biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products.

LigaChem Biosciences

Market Cap: ₩3.6t

A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.

Yuhan

Market Cap: ₩6.5t

Operates as a pharmaceutical company in South Korea and internationally.